High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation-Reference-Cited by-同舟云学术

High Disease Burden Is Associated with Poor Outcomes for Patients with Acute Myeloid Leukemia Not in Remission Who Undergo Unrelated Donor Cell Transplantation

Published:2006-01 Issue:1 Volume:12 Page:61-67
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Blum William,Bolwell Brian J.,Phillips Gary,Farag Sherif S.,Lin Thomas S.,Avalos Belinda R.,Penza Sam L.,Marcucci Guido,Byrd John C.,Kalaycio Matt E.,Sobecks Ronald M.,Pohlman Brad,Brown Stacey,Elder Patrick J.,Copelan Edward A.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference21 articles.

1. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy;Biggs;Blood,1992

2. Bone marrow transplantation for primary refractory acute leukaemia;Mehta;Bone Marrow Transplant,1994

3. Allogeneic bone marrow transplantation after high-dose busulfan and cyclophosphamide in patients with acute nonlymphocytic leukemia;Geller;Blood,1989

4. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia;Michallet;Bone Marrow Transplant,2000

5. Unrelated donor marrow transplantation for acute myeloid leukemia;Sierra;Bone Marrow Transplant,2000

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes;Signal Transduction and Targeted Therapy;2023-02-27

2. Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes;2022-11-10

3. Pretransplant increasing rate of lactate dehydrogenase as a predictor of transplant outcomes for patients with myeloid hematological malignancies;Bone Marrow Transplantation;2021-03-08

4. Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation;Annals of Hematology;2019-07-16

5. High-dose melphalan-based sequential conditioning chemotherapy followed by allogeneic haematopoietic stem cell transplantation in adult patients with relapsed or refractory acute myeloid leukaemia;British Journal of Haematology;2018-02-21